Platelet PlA2 polymorphism and thromboembolic events: From inherited risk to pharmacogenetics

被引：13

作者：

Goldschmidt-Clermont, PJ

Roos, CM

Cooke, GE

机构：

[1] Ohio State Univ, Heart & Lung Inst, Coll Med & Publ Hlth, Columbus, OH 43210 USA

[2] Ohio State Univ, Coll Med & Publ Hlth, Div Cardiol, Columbus, OH 43210 USA

来源：

JOURNAL OF THROMBOSIS AND THROMBOLYSIS | 1999年 / 8卷 / 02期

关键词：

platelet polymorphism; myocardial infarction; aspirin; pharmacogenetics; review;

D O I：

10.1023/A:1008954916972

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：89 / 103

页数：15

共 118 条

[1] Role of platelet glycoprotein pLA1/A2 polymorphism in restenosis after percutaneous transluminal coronary angioplasty [J].

Abbate, R ;

Marcucci, R ;

Camacho-Vanegas, O ;

Pepe, G ;

Gori, AM ;

Capanni, M ;

Simonetti, I ;

Prisco, D ;

Gensini, GF .

AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (04) :524-+

[2] Sequence 274-368 in the beta 3-subunit of the integrin alpha IIb beta 3 provides a ligand recognition and binding domain for the gamma-chain of fibrinogen that is independent of platelet activation [J].

Alemany, M ;

Concord, E ;

Garin, J ;

Vincon, M ;

Giles, A ;

Marguerie, G ;

Gulino, D .

BLOOD, 1996, 87 (02) :592-601

[3] Prevalence of hypercholesterolemia among siblings of persons with premature coronary heart disease - Application of the second Adult Treatment Panel guidelines [J].

Allen, JK ;

Young, DR ;

Blumenthal, RS ;

Moy, TF ;

Yanek, LR ;

Wilder, L ;

Becker, LC ;

Becker, DM .

ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (15) :1654-1660

[4] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].

ALTMAN, R ;

CARRERAS, L ;

DIAZ, R ;

FIGUEROA, E ;

PAOLASSO, E ;

PARODI, JC ;

CADE, JF ;

DONNAN, G ;

EADIE, MJ ;

GAVAGHAN, TP ;

OSULLIVAN, EF ;

PARKIN, D ;

RENNY, JTG ;

SILAGY, C ;

VINAZZER, H ;

ZEKERT, F ;

ADRIAENSEN, H ;

BERTRANDHARDY, JM ;

BRAN, M ;

DAVID, JL ;

DRICOT, J ;

LAVENNEPARDONGE, E ;

LIMET, R ;

LOWENTHAL, A ;

MORIAU, M ;

SCHAPIRA, S ;

SMETS, P ;

SYMOENS, J ;

VERHAEGHE, R ;

VERSTRAETE, M ;

ATALLAH, A ;

BARNETT, H ;

BATISTA, R ;

BLAKELY, J ;

CAIRNS, JA ;

COTE, R ;

CROUCH, J ;

EVANS, G ;

FINDLAY, JM ;

GENT, M ;

LANGLOIS, Y ;

LECLERC, J ;

NORRIS, J ;

PINEO, GF ;

POWERS, PJ ;

ROBERTS, R ;

SCHWARTZ, L ;

SICURELLA, J ;

TAYLOR, W ;

THEROUX, P .

BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100

[5]

[Anonymous], 1988, NEW ENGL J MED, V318, P262

[6]

[Anonymous], 1988, LANCET, V2, P349

[7]

[Anonymous], 1976, JAMA, V235, P825

[8] FAMILY HISTORY OF HEART-ATTACK AS AN INDEPENDENT PREDICTOR OF DEATH DUE TO CARDIOVASCULAR-DISEASE [J].

BARRETTCONNOR, E ;

KHAW, K .

CIRCULATION, 1984, 69 (06) :1065-1069

[9]

Bazzino O, 1998, NEW ENGL J MED, V338, P1498

[10] Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers [J].

Benedek, IH ;

Joshi, AS ;

Pieniaszek, HJ ;

King, SYP ;

Kornhauser, DM .

JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (12) :1181-1186

← 1 2 3 4 5 6 7 8 9 10 →